LSM12-EPAC1 defines a neuroprotective pathway that sustains the nucleocytoplasmic RAN gradient

PLoS Biol. 2020 Dec 23;18(12):e3001002. doi: 10.1371/journal.pbio.3001002. eCollection 2020 Dec.

Abstract

Nucleocytoplasmic transport (NCT) defects have been implicated in neurodegenerative diseases such as C9ORF72-associated amyotrophic lateral sclerosis and frontotemporal dementia (C9-ALS/FTD). Here, we identify a neuroprotective pathway of like-Sm protein 12 (LSM12) and exchange protein directly activated by cyclic AMP 1 (EPAC1) that sustains the nucleocytoplasmic RAN gradient and thereby suppresses NCT dysfunction by the C9ORF72-derived poly(glycine-arginine) protein. LSM12 depletion in human neuroblastoma cells aggravated poly(GR)-induced impairment of NCT and nuclear integrity while promoting the nuclear accumulation of poly(GR) granules. In fact, LSM12 posttranscriptionally up-regulated EPAC1 expression, whereas EPAC1 overexpression rescued the RAN gradient and NCT defects in LSM12-deleted cells. C9-ALS patient-derived neurons differentiated from induced pluripotent stem cells (C9-ALS iPSNs) displayed low expression of LSM12 and EPAC1. Lentiviral overexpression of LSM12 or EPAC1 indeed restored the RAN gradient, mitigated the pathogenic mislocalization of TDP-43, and suppressed caspase-3 activation for apoptosis in C9-ALS iPSNs. EPAC1 depletion biochemically dissociated RAN-importin β1 from the cytoplasmic nuclear pore complex, thereby dissipating the nucleocytoplasmic RAN gradient essential for NCT. These findings define the LSM12-EPAC1 pathway as an important suppressor of the NCT-related pathologies in C9-ALS/FTD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Active Transport, Cell Nucleus
  • Amyotrophic Lateral Sclerosis / genetics
  • Amyotrophic Lateral Sclerosis / metabolism
  • Amyotrophic Lateral Sclerosis / pathology
  • C9orf72 Protein / genetics
  • C9orf72 Protein / metabolism
  • Cell Nucleus / metabolism
  • Circadian Rhythm Signaling Peptides and Proteins / genetics
  • Circadian Rhythm Signaling Peptides and Proteins / metabolism*
  • Cyclic AMP / metabolism
  • Cytoplasm / metabolism
  • Frontotemporal Dementia / genetics
  • Frontotemporal Dementia / metabolism
  • Frontotemporal Dementia / pathology
  • Guanine Nucleotide Exchange Factors / genetics
  • Guanine Nucleotide Exchange Factors / metabolism*
  • Humans
  • Induced Pluripotent Stem Cells / metabolism
  • Neurons / metabolism
  • Neurons / pathology
  • Nuclear Pore / metabolism
  • Nucleocytoplasmic Transport Proteins / genetics
  • Nucleocytoplasmic Transport Proteins / metabolism*
  • ran GTP-Binding Protein / metabolism*

Substances

  • C9orf72 Protein
  • C9orf72 protein, human
  • Circadian Rhythm Signaling Peptides and Proteins
  • Guanine Nucleotide Exchange Factors
  • Nucleocytoplasmic Transport Proteins
  • RAN protein, human
  • RAPGEF3 protein, human
  • Cyclic AMP
  • ran GTP-Binding Protein

Grants and funding

This work was supported by grants from the Suh Kyungbae Foundation (SUHF-17020101[CL]); from the National Research Foundation funded by the Ministry of Science and Information & Communication Technology (MSIT), Republic of Korea (NRF-2018R1A2B2004641[CL]; NRF-2018R1A5A1024261[KJY, YKK, and CL]); and from the Korea Health Technology R&D Project through the KHIDI funded by the Ministry of Health & Welfare, Republic of Korea (HI16C1747[CL]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.